Skip to main navigation Skip to search Skip to main content

Horizontal mitochondrial transfer in cancer biology: Potential clinical relevance

  • Michael V. Berridge*
  • , Renata Zobalova
  • , Stepana Boukalova
  • , Andrés Caicedo
  • , Stuart A. Rushworth
  • , Jiri Neuzil*
  • *Corresponding author for this work
  • Malaghan Institute of Medical Research
  • Institute of Biotechnology of the Academy of Sciences of the Czech Republic
  • Mito-Act Research Consortium
  • University of East Anglia
  • Griffith University
  • Charles University

Research output: Contribution to journalComment/debate

19 Scopus citations

Abstract

Recent research highlights horizontal mitochondrial transfer as a key biological phenomenon linked to cancer onset and progression. The transfer of mitochondria and their genomes between cancer and non-cancer cells shifts our understanding of intercellular gene trafficking, increasing the metabolic fitness of cancer cells and modulating antitumor immune responses. This process not only facilitates tumor progression but also presents potential therapeutic opportunities.

Original languageEnglish
Pages (from-to)803-807
Number of pages5
JournalCancer Cell
Volume43
Issue number5
DOIs
StatePublished - 12 May 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Horizontal mitochondrial transfer in cancer biology: Potential clinical relevance'. Together they form a unique fingerprint.

Cite this